NCT07059559 is a NA clinical trial of Rhythmic walking in Renal Function, sponsored by Burapha University.

Who is sponsoring NCT07059559?

NCT07059559 is sponsored by Burapha University.

What drugs are being tested in NCT07059559?

Interventions in NCT07059559: Rhythmic walking.

What condition does NCT07059559 study?

NCT07059559 studies Renal Function.

Is NCT07059559 still recruiting?

NCT07059559 is currently completed. Last updated 11 July 2025.

Last reviewed 2025-07-11 · How we verify

NCT07059559

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Rhythmic Walking Program and Renal Function and Oxidative Stress

Completed NA Last updated 11 July 2025

What this trial tests

NA trial testing Rhythmic walking in Renal Function in 64 participants. Completed in 1 July 2025.

Timeline

17 July 2024

Primary endpoint
1 July 2025

1 July 2025

Quick facts

Lead sponsor	Burapha University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	64
Start date	17 July 2024
Primary completion	1 July 2025
Estimated completion	1 July 2025
Sites	1 location across Thailand

Drugs / interventions tested

Rhythmic walking

Conditions studied

Renal Function — all drugs for Renal Function →

Sponsor

Burapha University

Who can join

Adults 18 to 59, any sex, with Renal Function. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study designed a over-knee automatic step counter device. Then, we evaluated its efficacy on renal function and oxidative stress in patients with chronic kidney disease.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Rhythmic Walking Exercise as a Low-Intensity Strategy to Enhance Health and Preserve Kidney Function in Individuals with CKD Stages 2-3.
Suvannarot P, Roengrit T, Anuchitchanchai P, Prasertsri P. · · 2025 · PMID 41302159 · DOI 10.3390/life15111735

Verify or expand the search:

Other recruiting trials for Renal Function

Currently open trials in the same condition.

NCT06838416 — Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney Disease · recruiting
NCT04334135 — The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function · NA · recruiting

Other Burapha University trials

Trials by the same sponsor.

NCT07056764 — Development of Lung Vibration Equipment · NA · completed
NCT07495670 — Comparison of 4 Methods of Eye Drops for Pupil Dilation in Diabetic Patients · NA · completed
NCT07018128 — Expression of Genes Relating Hypertension and Efficacy of 4-7-8 Breathing Control on Reducing Blood Pressure · NA · recruiting
NCT07500272 — Agreement of Ocular Biometry and Intraocular Lens Power Between OA-2000 and Pentacam AXL in Cataract Patients · completed
NCT06475222 — Facial Serum and Mask and Ready-to-drink Jelly From Thai Rice · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07059559 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Burapha University
Last refreshed: 11 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07059559.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing